GenScript ProBio

GenScript ProBio’s innovative solutions for antibody drug development include antibody drug discovery (hybridoma, antibody library, fully human transgenic mice, bispecific antibodies technologies, single b cell screening technology), antibody engineering (antibody humanization, affinity maturation, Fc Engineering) and antibody characterization (analytics and bioassays). In terms of biologics development service, GenScript ProBio has built a regulatory-compliant platform, from stable cell line development, host cell license, process development, analytical development to clinical manufacturing services, providing fed-batch and perfusion process to accelerate IND process and high-quality material for clinical trials. GenScript ProBio has successfully delivered multiple CMC and GMP manufacturing projects. GenScript ProBio is the world's leading biotech company founded in 2002 in New Jersey USA. We at GenScript ProBio started business from gene synthesis and now provide various solutions based on gene synthesis technology including gene and cell therapy vector, biologics development and lentivirus manufacturing, GMP lentivirus, CAR-T IND filing, plasmid manufacturing & production, mRNA plasmid, clinical plasmid and many more. GenScript ProBio has also established an integrated innovative biologics CDMO platforms which covering two major services areas such as therapeutic antibody drug and gene & cell therapy.